Skip to main content
Richard Schlenk, MD, Neurosurgery, Cleveland, OH, Cleveland Clinic

RichardSchlenkMD

Neurosurgery Cleveland, OH

Neurosurgical Spine Surgery

Neurosurgery Residency Program Director at Cleveland Clinic

Dr. Schlenk is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Schlenk's full profile

Already have an account?

Education & Training

  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationFellowship, Neurosurgical Spine Surgery, 2002 - 2003
  • Rutgers Health/New Jersey Medical School
    Rutgers Health/New Jersey Medical SchoolResidency, Neurological Surgery, 1997 - 2002
  • Rutgers Health/New Jersey Medical School
    Rutgers Health/New Jersey Medical SchoolResidency, Surgery, 1995 - 1997
  • Rutgers New Jersey Medical School
    Rutgers New Jersey Medical SchoolClass of 1995

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2002 - 2026
  • NJ State Medical License
    NJ State Medical License 1998 - 2003
  • American Board of Neurological Surgery Neurological Surgery

Awards, Honors, & Recognition

  • Fellow (FAANS) American Association of Neurological Surgeons

Publications & Presentations

PubMed

Press Mentions

  • VANFLYTA® Approved in the EU as the First FLT3 Inhibitor Specifically for Patients with Newly Diagnosed FLT3-ITD Positive AML
    VANFLYTA® Approved in the EU as the First FLT3 Inhibitor Specifically for Patients with Newly Diagnosed FLT3-ITD Positive AMLNovember 10th, 2023

Professional Memberships

Hospital Affiliations